We have not tested nor approved COA FS as a treatment for pandemic novel Coronavirus, according to the Noguchi Memorial Institute for Medical Research (NMIMR).
The research Institute refuted this after some media publications claimed that Noguchi had approved the local medicine for treatment for COVID-19 patients.
Noguchi in a release on its Twitter page indicated that such publications are false and misleading.
The Director of Noguchi Memorial Institute for Medical Research, Prof Abraham Kwabena Annan in an interview clarified that the drug in its current state cannot treat COVID-19.
“We have not tested it so…as to whether it will work against it [Coronavirus], it has to be tested. We are in touch with the manufacturers but we are not the ones who will test it under the circumstances. The GHS, FDA ourselves and other parties must come together to determine how that kind of thing works”
Meanwhile, Executive President of the Centre of Awareness Food Supplement (COA FS), manufactures of COA FS, Prof. Samuel Ato Duncan, had stated in an earlier interview that the drug can cure the deadly coronavirus.
Reports indicate that the claim has attracted wide interest with some members of the public rushing to purchase the product.